Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis BioCryst Pharmaceuticals Inc BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more

Opinion & Analysis (NDAQ:BCRX)

BioCryst Data Point, Ghana Tour & Avanti in B.C.

Thom Calandra August 6, 2009

BioCryst Interview, Lithium, Linear & Guanajuato: Ticker Trax

Thom Calandra August 5, 2009

Ticker Trax Update: BioCryst: Event in offing

Thom Calandra July 1, 2009

Stock picks and coal plays Cotton likes

J.W. Cotton May 22, 2009

Silver coins – no chump change here

Thom Calandra May 5, 2009

Ivanhoe Energy, BioCryst & more: ThomWatch

Thom Calandra May 1, 2009

How one investor took the wrong drug: ThomWatch

Thom Calandra December 12, 2008